Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Hyperbilirubinemia × Carnitine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Breast Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neurotoxicity Syndromes 1 Hyperbilirubinemia 1 Heart Failure 1

Interventions

Vitamin B Complex 1 Folic Acid 1 Carnitine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03564678 2025-09-05

Levocarnitine and Vitamin B Complex in Treating PEG-Asparaginase or Inotuzumab Ozogamicin-Induced Hyperbilirubinemia in Patients With Acute Lymphoblastic Leukemia

M.D. Anderson Cancer Center

Phase 2 Terminated

10 enrolled 5 charts

LymphoidOther hematologic neoplasm

Hyperbilirubinemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡